Lucas Montarce - 09 Sep 2024 Form 3 Insider Report for ELI LILLY & Co (LLY)

Role
EVP & CFO
Signature
/s/ Jonathan Groff for Lucas E. Montarce, pursuant to attached authorization
Issuer symbol
LLY
Transactions as of
09 Sep 2024
Net transactions value
$0
Form type
3
Filing time
18 Sep 2024, 16:19:42 UTC
Next filing
05 Nov 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding LLY Common Stock 10,467 09 Sep 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding LLY Restricted Stock Unit 09 Sep 2024 Common Stock 371 Direct F1
holding LLY Restricted Stock Unit 09 Sep 2024 Common Stock 1,074 Direct F1
holding LLY Restricted Stock Unit 09 Sep 2024 Common Stock 368 Direct F1
holding LLY Restricted Stock Unit 09 Sep 2024 Common Stock 1,610 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.

Remarks:

Exhibit 24 - Power of Attorney